152 related articles for article (PubMed ID: 3948188)
1. Role of murine tumor models in cancer treatment research.
Martin DS; Balis ME; Fisher B; Frei E; Freireich EJ; Heppner GH; Holland JF; Houghton JA; Houghton PJ; Johnson RK
Cancer Res; 1986 Apr; 46(4 Pt 2):2189-92. PubMed ID: 3948188
[TBL] [Abstract][Full Text] [Related]
2. Nude mouse models as predictors of chemotherapy in man: thymidine and pyrimidines.
Goldin A; Wolpert-Defilippes MK
Bull Cancer; 1979; 66(1):61-6. PubMed ID: 420948
[TBL] [Abstract][Full Text] [Related]
3. Human tumor testsystems: a new screening approach.
Kraemer HP; Sedlacek HH
Behring Inst Mitt; 1986 Jun; (80):103-12. PubMed ID: 3753367
[TBL] [Abstract][Full Text] [Related]
4. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy.
Hoffman RM
Methods Mol Med; 2005; 111():297-322. PubMed ID: 15911987
[TBL] [Abstract][Full Text] [Related]
5. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
Man S; Munoz R; Kerbel RS
Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
[TBL] [Abstract][Full Text] [Related]
6. [Preclinical evaluation of anticancer drugs: a model remaining a model!].
Lavelle F
Bull Cancer; 1998 Oct; 85(10):837-42. PubMed ID: 9835860
[TBL] [Abstract][Full Text] [Related]
7. A murine plasmacytoma model for screening active drugs for human myeloma.
Hiramoto RN; Ghanta VK; Durant JR; Hiramoto NS
Cancer Clin Trials; 1980; 3(4):395-402. PubMed ID: 7428144
[TBL] [Abstract][Full Text] [Related]
8. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.
Kelland LR
Eur J Cancer; 2004 Apr; 40(6):827-36. PubMed ID: 15120038
[TBL] [Abstract][Full Text] [Related]
9. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
[TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
11. Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.
Voskoglou-Nomikos T; Pater JL; Seymour L
Clin Cancer Res; 2003 Sep; 9(11):4227-39. PubMed ID: 14519650
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of human tumors in T-lymphocyte-deficient mice.
Mitchley BC; Clarke SA; Connors TA; Carter SM; Neville AM
Cancer Treat Rep; 1977; 61(3):451-62. PubMed ID: 406045
[TBL] [Abstract][Full Text] [Related]
13. [Value of experimental results in clinical tumor chemotherapy (author's transl)].
Somfai-Relle S; Sugár J
Arch Geschwulstforsch; 1980; 50(2):132-40. PubMed ID: 7436697
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-Annexin A5 uptake and imaging to monitor chemosensitivity.
Belhocine TZ; Blankenberg FG
Methods Mol Med; 2005; 111():363-80. PubMed ID: 15911991
[TBL] [Abstract][Full Text] [Related]
15. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.
Shalinsky DR; Brekken J; Zou H; Bloom LA; McDermott CD; Zook S; Varki NM; Appelt K
Clin Cancer Res; 1999 Jul; 5(7):1905-17. PubMed ID: 10430098
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J
Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334
[TBL] [Abstract][Full Text] [Related]
17. Assessing growth and response to therapy in murine tumor models.
Reynolds CP; Sun BC; DeClerck YA; Moats RA
Methods Mol Med; 2005; 111():335-50. PubMed ID: 15911989
[TBL] [Abstract][Full Text] [Related]
18. In vivo evaluation of ixabepilone (BMS247550), a novel epothilone B derivative, against pediatric cancer models.
Peterson JK; Tucker C; Favours E; Cheshire PJ; Creech J; Billups CA; Smykla R; Lee FY; Houghton PJ
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6950-8. PubMed ID: 16203787
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors.
Li C; Price JE; Milas L; Hunter NR; Ke S; Yu DF; Charnsangavej C; Wallace S
Clin Cancer Res; 1999 Apr; 5(4):891-7. PubMed ID: 10213226
[TBL] [Abstract][Full Text] [Related]
20. [Effect of antineoplastic agents and ionizing radiation on a human testicular cancer heterograft].
Osieka R; Bamberg M; Pfeiffer R; Glatte P; Scherer E; Schmidt CG
Strahlentherapie; 1985 Jan; 161(1):35-46. PubMed ID: 3969692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
